Venn Life Sciences completes Innovenn UK stake sale

Venn Life Sciences has completed the sale of its shareholding in Innovenn UK Ltd to Integumen Ltd and notes that company is currently going through an IPO process. Venn is receiving ordinary shares of £1 each in Integumen as consideration.